The eye care supplement market is projected to be worth USD 2,457.5 million in 2024. The market is likely to reach USD 4,613.0 million by 2034. The market is further expected to surge at a CAGR of 6.5% during the forecast period 2024 to 2034.
| Attributes | Key Insights |
|---|---|
| Eye Care Supplement Market Estimated Size in 2024 | USD 2,457.5 million |
| Projected Market Value in 2034 | USD 4,613.0 million |
| Value-based CAGR from 2024 to 2034 | 6.5% |
Exclusive Offer: 30% Off on Regional Reports
Get a free sample report and customize your regions for a 30% discount on your regional report!
The scope for eye care supplement rose at a 6.0% CAGR between 2019 and 2023. The global market for eye care supplement is anticipated to grow at a moderate CAGR of 6.5% over the forecast period 2024 to 2034.
| Report Attributes | Details |
|---|---|
| Market Value in 2019 | USD 1,809.9 million |
| Market Value in 2023 | USD 2,301.8 million |
| CAGR from 2019 to 2023 | 6.0% |
The eye care supplement market experienced a significant growth during the historical period from 2019 to 2023. The aging global population was likely a significant driver, leading to a rise in age related eye conditions and an increased demand for eye care supplements. Rising awareness of the importance of preventive health measures and the role of nutrition in maintaining eye health likely contributed to the growth of the eye care supplement market.
The proliferation of digital devices and concerns about the impact of blue light on eye health may have driven the development and adoption of supplements targeting digital eye strain. Ongoing research and innovation in supplement formulations, including the use of scientifically proven ingredients, likely played a role in market growth.
The forecast period from 2024 to 2034 is expected to witness accelerated growth in the market. Continued advancements in supplement delivery systems and technology are expected to enhance the bioavailability and effectiveness of eye care supplements. The trend of personalized nutrition, possibly guided by genetic testing, may lead to the development of highly customized eye care supplement regimens.
Increased integration of digital tools, such as mobile apps for tracking eye health and supplement adherence, may enhance consumer engagement and contribute to market growth. The eye care supplement market may see increased expansion into emerging markets as healthcare awareness grows in those regions.
Clearer regulations and support for health claims related to eye health can enhance consumer trust and confidence, driving market growth. The adoption of holistic health approaches may lead to the development of supplements that address both eye health and overall well being. A growing understanding of the link between mental health and eye health can lead to the development of supplements targeting stress related eye issues.
Check Free Sample Report & Save 40%!
Select your niche segments and personalize your insights for smart savings. Cut costs now!
The below table showcases revenues in terms of the top 5 leading countries, spearheaded by the United States and China. The countries are expected to lead the market through 2034.
| Countries | Forecast CAGRs from 2024 to 2034 |
|---|---|
| The United States | 7.0% |
| Germany | 5.5% |
| The United Kingdom | 5.6% |
| China | 6.4% |
| India | 6.0% |
The eye care supplement market in the United States expected to expand at a CAGR of 7.0% through 2034. Growing awareness among the population of the United States about the importance of eye health and preventive measures has led to an increased interest in eye care supplements.
The broader trend toward preventive healthcare has influenced consumers to take proactive steps to maintain eye health, contributing to the demand for eye care supplements. Concerns about digital eye strain have risen, with the widespread use of digital devices in the United States. Eye care supplements addressing the effects of prolonged screen time have gained popularity.
The eye care supplement market in India is anticipated to expand at a CAGR of 6.0% through 2034. India is experiencing demographic changes, with an aging population. There is an increased risk of age related eye conditions, as individuals age in the country, which is expected to create a demand for supplements supporting eye health.
The expanding middle class population in India, coupled with increasing disposable income, provides consumers with the financial capacity to invest in health and wellness products, including eye care supplements.
The eye care supplement market in Germany is poised to expand at a CAGR of 5.5% through 2034. Government led health initiatives promoting preventive healthcare and wellness are expected to contribute to increased awareness and acceptance of eye care supplements in Germany.
Germany has stringent regulations for dietary supplements, providing consumers with confidence in the safety and quality of products. Regulatory support can positively influence market growth. The country has a culture that values an active lifestyle and fitness. The trend is likely to lead to the demand for supplements that support overall well being, including eye health.
Eye care supplement trends in China are taking a turn for the better. A 6.4% CAGR is forecast for the country from 2024 to 2034. Rapid urbanization and changing lifestyles in China have led to dietary shifts and increased reliance on processed foods. There is a growing interest in supplements to fill nutritional gaps.
The prevalence of e-commerce platforms in China facilitates easy access to a wide range of dietary supplements, making it convenient for consumers to purchase eye care supplements online. Traditional Chinese medicine places importance on holistic approaches to health. The cultural emphasis may contribute to the acceptance of supplements, including those for eye health.
The eye care supplement market in the United Kingdom is anticipated to expand at a CAGR of 5.6% through 2034. Collaborations between supplement manufacturers and healthcare professionals, such as ophthalmologists or optometrists, can enhance consumer trust and confidence in eye care supplements.
Deficiencies in essential vitamins and minerals, such as vitamin A, vitamin C, vitamin E, zinc, and omega-3 fatty acids, can impact eye health. Supplements addressing these deficiencies may see increased demand.
Growing consumer preference for natural and plant-based ingredients in supplements is expected to lead to the development of eye care supplements with botanical extracts and natural compounds known for their eye health benefits.
The below table highlights how lutein and zeaxanthin segment is projected to lead the market in terms of ingredients, and is expected to account for a share of 37.0% in 2024.
Based on dosage form, the tablet segment is expected to account for a share of 21.5% in 2024.
| Category | Shares in 2024 |
|---|---|
| Lutein and Zeaxanthin | 37.0% |
| Tablet | 21.5% |
Based on ingredients, the lutein and zeaxanthin segment is expected to continue dominating the eye care supplement market. The segment is expected to account for a share of 37.0% in 2024.
Lutein and zeaxanthin are carotenoids with strong antioxidant properties. Antioxidants help protect the eyes from oxidative stress caused by free radicals, contributing to overall eye health.
Lutein and zeaxanthin are particularly beneficial for maintaining macular health. The macula is a part of the retina responsible for central vision, and these carotenoids are known to accumulate in the macula, helping protect against age related macular degeneration.
Some studies suggest that higher dietary intake or supplementation of lutein and zeaxanthin may be associated with a reduced risk of developing cataracts, a common age related eye condition.
Lutein and zeaxanthin act as natural filters that protect the eyes from phototoxic damage caused by exposure to ultraviolet light. The protective effect contributes to overall eye health.
In terms of dosage form, the tablet segment is expected to continue dominating the eye care supplement market. The segment is expected to account for a share of 21.5% in 2024.
Tablets are a convenient and portable dosage form, making them easy for consumers to incorporate into their daily routines. The ease of storage and consumption contributes to the popularity of tablets as a preferred dosage form.
Tablets offer precise dosage control, ensuring that consumers receive consistent amounts of active ingredients, which is particularly important for eye care supplements where accurate dosing is essential for optimal results.
Tablets generally have a longer shelf life compared to some other dosage forms, providing stability for eye care supplements and reducing the likelihood of product degradation over time.
The manufacturing process for tablets is well established and standardized, allowing for efficient production and stringent quality control, which contributes to the reliability and consistency of tablet formulations.
The key strategies chosen by large companies include several growth strategies such as technology development, expansion as well and mergers and acquisitions to surge market share, reach and revenue.
| Attribute | Details |
|---|---|
| Estimated Market Size in 2024 | USD 2,457.5 million |
| Projected Market Valuation in 2034 | USD 4,613.0 million |
| Value-based CAGR 2024 to 2034 | 6.5% |
| Forecast Period | 2024 to 2034 |
| Historical Data Available for | 2019 to 2023 |
| Market Analysis | Value in USD million |
| Key Regions Covered | North America Latin America Western Europe Eastern Europe South Asia and Pacific East Asia The Middle East & Africa |
| Key Market Segments Covered | Ingredients Dosage Form Route of Administration Indication Distribution Channel Region |
| Key Countries Profiled | The United States Canada Brazil Mexico Germany France France Spain Italy Russia Poland Czech Republic Romania India Bangladesh Australia New Zealand China Japan South Korea GCC countries South Africa Israel |
| Key Companies Profiled | Novartis AG; Bausch & Lomb Incorporated; Amway Corp.; Vitabiotics Ltd.; Alliance Pharma; The Nature's Bounty Co; ZeaVision, LLC.; Akorn Consumer Health; Eyescience Labs; Kemin Industries Inc.; NutraChamps; Nutrivein; Biosyntrx Inc; Nordic Naturals Inc.; Bristol-Myers Squibb Company; Healths Harmony LLC; NUSAPURE; Vitabiotics Ltd.; EyeScience; Butterflies Healthcare Ltd.; Allergan plc; Herbalife Nutrition Ltd. |
The market is expected to reach USD 2,457.5 million in 2024.
The market is set to expand by a CAGR of 6.5% by 2034.
The market is forecast to reach USD 4,613.0 million by 2034.
The United States is to be the top performing market, with a CAGR of 7.0% through 2034.
Lutein and Zeaxanthin segment is preferred, and is expected to account for a share of 37.0% in 2024.
| Estimated Size, 2025 | USD 8,125.2 million |
|---|---|
| Projected Size, 2035 | USD 11,890.2 million |
| CAGR (2025 to 2035) | 3.9% |
| Estimated Market Size (2024E) | USD 74.3 billion |
|---|---|
| Projected Market Valuation (2034F) | USD 170.1 billion |
| Value-based CAGR (2024 to 2034) | 9.5% |
| Estimated Market Size (2023) | USD 2,679 million |
|---|---|
| Projected Market Value (2033) | USD 4,456 million |
| Value-based Market CAGR (2023 to 2033) | 13.6% |
| Market Size, 2023 | USD 57.63 billion |
|---|---|
| Market Size, 2033 | USD 133.94 billion |
| Value-based CAGR from 2023 to 2033 | 8.8% |
Explore Pharmaceuticals Insights
View Reports
Eye Care Supplement Market
Thank you!
You will receive an email from our Business Development Manager. Please be sure to check your SPAM/JUNK folder too.
